CN Patent

CN111989095A — 预防或治疗肿瘤疗法副作用的方法

Assigned to Shanghai Ankao Pharmaceutical Technology Co ltd · Expires 2020-11-24 · 5y expired

What this patent protects

本发明公开了一氧化氮释放剂在制备药物中的用途，所述药物用于预防或治疗与施用VEGFR抑制剂和/或VEGF抑制剂相关的疾病或病症。本申请还提供预防或者治疗与施用VEGFR抑制剂和/或VEGF抑制剂相关的疾病或病症的方法，所述方法可包括向有需要的受试者施用预防或治疗有效量的一氧化氮释放剂。

USPTO Abstract

本发明公开了一氧化氮释放剂在制备药物中的用途，所述药物用于预防或治疗与施用VEGFR抑制剂和/或VEGF抑制剂相关的疾病或病症。本申请还提供预防或者治疗与施用VEGFR抑制剂和/或VEGF抑制剂相关的疾病或病症的方法，所述方法可包括向有需要的受试者施用预防或治疗有效量的一氧化氮释放剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN111989095A
Jurisdiction
CN
Classification
—
Expires
2020-11-24
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Ankao Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.